Oncology
Probiotics such as Lactobacillus and Bifidobacterium can activate a person’s immune system and improve the response to some anti-cancer therapies.
TCGA allows to explore the role of tissue-resident microbiota in various cancer types and identifying predictive microbial biomarkers.
Decreased microbial diversity and increased abundance of Firmicutes phylum in the respiratory tract may be associated with an increased risk of lung cancer.
Researches suggest that Lachnospiraceae and Enterococcaceae, as well as bacterial metabolites such as propionate can contribute to radioprotection.
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Researchers have found that the development of liver cancer can be associated with alterations of the gut microbiota.
Researchers have found that the gut microbiota and the death of intestinal cells caused by chemotherapy can enhance the immune response of people with colon cancer.
We discussed the role of the microbiome in HPV-positive head and neck cancer patients with Marc Oliva Bernal (Institut Català d’Oncologia, Spain).
Does the microbiota contribute to breast cancer development? We asked this question to Sridhar Mani, from the Albert Einstein College of Medicine in New York (USA).
